CAPTRUST Financial Advisors
LABU icon

CAPTRUST Financial Advisors’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

CAPTRUST Financial Advisors’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,256
Closed -$176K – 2128
2022
Q3 		$176K Buy
1,256
+128
+11% +$23.5K ﹤0.01% 1845
2022
Q2 		$152K Buy
1,128
+561
+99% +$95.5K ﹤0.01% 1895
2022
Q1 		$178K Buy
567
+563
+14,075% +$212K ﹤0.01% 1810
2021
Q4 		$3K Buy
+4
New +$3.83K ﹤0.01% 4282

Other funds holding LABU

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AIP
Ahrens Investment Partners Lafayette, Louisiana $202M AUM 3.91% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CAPTRUST Financial Advisors's LABU Position: Q4 2022 in Review

CAPTRUST Financial Advisors sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2022, closing a stake of 1,256 shares — an estimated $176K sold.

CAPTRUST Financial Advisors first reported a position in LABU in Q4 2021 and held it in 4 quarters. The position peaked at $178K in Q1 2022. 49 funds tracked by Wall St. Rank hold LABU as of Q4 2022.

  • CAPTRUST Financial Advisors reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 1,256 Direxion Daily S&P Biotech Bull 3X ETF shares in Q4 2022, an estimated $176K.
  • CAPTRUST Financial Advisors first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2021 and held it in 4 quarters.
  • CAPTRUST Financial Advisors's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $178K in Q1 2022.
  • 49 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.